SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Ekblom Berit) "

Sökning: WFRF:(Ekblom Berit)

  • Resultat 1-10 av 13
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
1.
  • Ekblom, Berit, et al. (författare)
  • Effects of the hip abduction orthosis on muscle activity in children with Cerebral Palsy
  • 2002
  • Ingår i: Physiotherapy Theory and Practice. - : Informa UK Limited. - 0959-3985 .- 1532-5040. ; 18:2, s. 55-63
  • Tidskriftsartikel (refereegranskat)abstract
    • Hip abduction orthoses are commonly used as adjuncts to create a symmetrical and stable sitting position for children with spastic diplegia. This study investigated how activity in m. Adductor longus, m. Rectus femoris, m. Gastrocnemius and m. Erector spinae was affected while sitting in a ''functional sitting position'' (FSP) performing five upper extremity tasks under four test conditions, one without hip orthosis and three with the orthosis set at three different spring lengths. The experimental group consisted of four children with spastic diplegia (mean age 4 years), while five healthy children (mean age 7 years) served as controls. The initial hip abduction angle adopted spontaneously by each child was measured by a goniometer. Muscle activity was measured by surface electromyography (EMG) during three minutes under each test condition. The children in the experimental group were also assessed from videofilms with the Sitting Assessment Scale (SAS) and the SAS scores were compared to the EMG results. The results of the study failed to demonstrate significant difference in EMG voltage under different sitting conditions, without or with hip abduction orthosis adjusted to varying hip abduction positions. This may imply that if a functional sitting position is assured, further addition of an orthosis is not needed. Follow-up study on a larger group of children with CP may be advisable
  •  
2.
  •  
3.
  • El Missiry, Mohamed, et al. (författare)
  • Assessment of bone marrow lymphocytic status during tyrosine kinase inhibitor therapy and its relation to therapy response in chronic myeloid leukaemia
  • 2016
  • Ingår i: Journal of Cancer Research and Clinical Oncology. - : Springer Science and Business Media LLC. - 0171-5216 .- 1432-1335. ; 142:5, s. 1041-1050
  • Tidskriftsartikel (refereegranskat)abstract
    • Tyrosine kinase inhibitors (TKIs) used in the treatment of chronic myeloid leukaemia have been reported to induce immunomodulatory effects. We aimed to assess peripheral blood (PB) and bone marrow (BM) lymphocyte status at the diagnosis and during different TKI therapies and correlate it with treatment responses. BM and PB samples were acquired from 105 first-line TKI-treated patients. Relative number of BM lymphocytes was evaluated from MGG-stained BM aspirates, and immunophenotypic analyses were performed with multicolour flow cytometry. Early 3-month expansion of BM lymphocytes was found during all different TKIs (imatinib n = 71, 20 %; dasatinib n = 25, 21 %; nilotinib n = 9, 22 %; healthy controls n = 14, 12 %, p < 0.0001). Increased PB lymphocyte count was only observed during dasatinib therapy. The BM lymphocyte expansion was associated with early molecular response; patients with 3-month BCR-ABL1 < 10 % showed higher lymphocyte counts than patients with BCR-ABL1 > 10 % (23 vs. 17 %, p < 0.05). Detailed phenotypic analysis showed that BM lymphocyte expansion consisted of various lymphocyte subclasses, but especially the proportion of CD19+ B cells and CD3negCD16/56+ NK cells increased from diagnostic values. During dasatinib treatment, the lymphocyte balance in both BM and PB was shifted more to cytotoxic direction (increased CD8+CD57+ and CD8+HLA-DR+ cells, and low T regulatory cells), whereas no major immunophenotypic differences were observed between imatinib and nilotinib patients. Early BM lymphocytosis occurs with all current first-line TKIs and is associated with better treatment responses. PB and BM immunoprofile during dasatinib treatment markedly differs from both imatinib- and nilotinib-treated patients.
  •  
4.
  •  
5.
  • Höglund, Martin, et al. (författare)
  • Tyrosine kinase inhibitor usage, treatment outcome, and prognostic scores in CML: report from the population-based Swedish CML registry
  • 2013
  • Ingår i: Blood. - : American Society of Hematology. - 0006-4971 .- 1528-0020. ; 122:7, s. 1284-1292
  • Tidskriftsartikel (refereegranskat)abstract
    • Clinical management guidelines on malignant disorders are generally based on data from clinical trials with selected patient cohorts. In Sweden, more than 95% of all patients diagnosed with chronic myeloid leukemia (CML) are reported to the national CML registry, providing unique possibilities to compile population-based information. This report is based on registry data from 2002 to 2010, when a total of 779 patients (425 men, 354 women; median age, 60 years) were diagnosed with CML (93% chronic, 5% accelerated, and 2% blastic phase) corresponding to an annual incidence of 0.9/100 000. In 2002, approximately half of the patients received a tyrosine kinase inhibitor as initial therapy, a proportion that increased to 94% for younger (andlt;70 years) and 79% for older (andgt;80 years) patients during 2007-2009. With a median follow-up of 61 months, the relative survival at 5 years was close to 1.0 for patients younger than 60 years and 0.9 for those aged 60 to 80 years, but only 0.6 for those older than 80 years. At 12 months, 3% had progressed to accelerated or blastic phase. Sokal, but not European Treatment and Outcome Study, high-risk scores were significantly linked to inferior overall and relative survival. Patients living in university vs nonuniversity catchment areas more often received tyrosine kinase inhibitors up front but showed comparable survival.
  •  
6.
  •  
7.
  •  
8.
  •  
9.
  • Malm, Christer, et al. (författare)
  • Leukocytes, cytokines, growth factors and hormones in human skeletal muscle and blood after uphill or downhill running.
  • 2004
  • Ingår i: The Journal of physiology. - : Wiley. - 0022-3751 .- 1469-7793. ; 556:Pt 3, s. 983-1000
  • Tidskriftsartikel (refereegranskat)abstract
    • Muscular adaptation to physical exercise has previously been described as a repair process following tissue damage. Recently, evidence has been published to question this hypothesis. The purpose of this study was to investigate inflammatory processes in human skeletal muscle and epimysium after acute physical exercise with large eccentric components. Three groups of subjects (n= 19) performed 45 min treadmill running at either 4 deg (n= 5) or 8 deg (n= 9) downhill or 4 deg uphill (n= 5) and one group served as control (n= 9). One biopsy was taken from each subject 48 h post exercise. Blood samples were taken up to 7 days post exercise. Compared to the control group, none of the markers of inflammation in muscle and epimysium samples was different in any exercised group. Only subjects in the Downhill groups experienced delayed onset of muscle soreness (DOMS) and increased serum creatine kinase activity (CK). The detected levels of immunohistochemical markers for T cells (CD3), granulocytes (CD11b), leukaemia inhibitory factor (LIF) and hypoxia-inducible factor 1beta (HIF-1beta) were greater in epimysium from exercised subjects with DOMS ratings >3 (0-10 scale) compared to exercised subjects without DOMS but not higher than controls. Eccentric physical exercise (downhill running) did not result in skeletal muscle inflammation 48 h post exercise, despite DOMS and increased CK. It is suggested that exercise can induce DOMS by activating inflammatory factors present in the epimysium before exercise. Repeated physical training may alter the content of inflammatory factors in the epimysium and thus reduce DOMS.
  •  
10.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 1-10 av 13
Typ av publikation
tidskriftsartikel (9)
rapport (4)
Typ av innehåll
övrigt vetenskapligt/konstnärligt (8)
refereegranskat (5)
Författare/redaktör
Olsson-Strömberg, Ul ... (6)
Ekblom, Marja (6)
Porkka, Kimmo (5)
Mustjoki, Satu (5)
Hjorth-Hansen, Henri ... (5)
Ekblom, Berit (5)
visa fler...
Höglund, Martin (4)
Malm, Claes (4)
Richter, Johan (4)
Lehmann, Soren (4)
Winkel, Jörgen (4)
Själander, Anders (4)
Markevärn, Berit (4)
Ohm, Lotta (4)
Stenke, Leif (4)
Saussele, Susanne (3)
Mahon, Francois-Xavi ... (3)
Söderlund, Stina (3)
Lübking, Anna (3)
Bjerrum, Ole Weis (2)
Ehrencrona, Hans (2)
Ekblom, Björn (2)
Lotfi, Kourosh (2)
Guilhot, Joelle (2)
El Missiry, Mohamed (2)
Al-Samadi, Ahmed (2)
Markevan, Berit (2)
Astrand-Grundstrom, ... (2)
Wold, Maren (2)
Juhl, Birgitte Ravn (2)
Haulin, Inger (2)
Ljungman, Per (1)
Simonsson, Bengt (1)
Lundberg, Ingrid E. (1)
Sandin, Fredrik (1)
Schantz, Peter (1)
Myhr, Ulla (1)
Bjorkholm, Magnus (1)
Wadenvik, Hans (1)
Awad, Shady Adnan (1)
Sjödin, Bertil (1)
Renström, Per (1)
Brune, Mats (1)
Bryceson, Yenan (1)
Malm, Christer (1)
Dreimane, Arta (1)
Myhr-Eriksson, Krist ... (1)
Rajala, Hanna L. (1)
Svedahl, Ellen Rabbe ... (1)
Adnan, Shady (1)
visa färre...
Lärosäte
Uppsala universitet (6)
Umeå universitet (5)
Luleå tekniska universitet (5)
Karolinska Institutet (4)
Gymnastik- och idrottshögskolan (2)
Linköpings universitet (1)
visa fler...
Lunds universitet (1)
visa färre...
Språk
Engelska (9)
Svenska (4)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (12)
Teknik (2)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy